LEIBER-X Technology

LEIBER is more than just a name; it is a core philosophy that drives our technology, rooted in the German concept of the "Living Body" (Leib /ˈlaɪbər/ (lye-ber)) and defined by our advanced methodological approach.

Beyond the Physical Body, Toward the Living Life

LEIBER-X

Single-cell Intelligence as a Service

Our solution runs on the LEIBER-X™ platform.

It works across all clinical Trial phases & offers adaptive clinical optimization.

Leveraging Extensive Intelligence for precision heuristics Beyond Exploratory Regulatory single-cell strategy

GRN + CNV Explainability

Gold-standard Reproducibility

Audit-ready Traceability

100K+ Archives Reactivated

<2.5 Week Pilots

Validator Sign-off

CDx Champion Enablement

How We De-Risk Your Journey

Transforming bulk tissue data into single-cell precision through AI-powered deconvolution

1

Single-Cell Core

Data Foundation

WittGen single-cell database with 1.3B+ cells provides the ground truth for all platform capabilities.

Comprehensive multi-cancer & healthy organ single-cell atlas
Validated cellular profiles across tumor types
High-quality reference data for deconvolution
Single-Cell Core
2

Bulk-to-Single Cell GenAI

Affordable Single-Cell Resolution

Transform $50 bulk RNA-seq into $4,000+ single-cell resolution profiles with cellular-level precision.

GenAI-powered deconvolution of bulk samples
Multimodal single-cell predictions
Cost-effective patient stratification
Bulk-to-Single Cell GenAI
3

Image-to-Omics

Image2SC Capability

Derive single-cell omics insights from imaging data to expand analytical capabilities.

Spatial context integration
Image-based cellular profiling
Complementary to molecular data
Image-to-Omics

Continuous Value Across Clinical Phases

From historical data analysis through
trial design, patient screening & outcome analysis

Historical Data AnalysisTrial DesignPatient ScreeningOutcome Analysis
Request Demo

Superior Data Quality = Superior Results

Our data-centric AI approach prioritizes quality over quantity. Well-curated datasets with precise annotation deliver significantly better model performance.

95% ML Accuracy

vs. 70% market standard

Subtyping
95%
Grade
92%
Cell Composition
98%

Our Competitive Edge

  • CNV inference scoring for cell-level validation
  • Manual expert curation + extra information mining
  • Golden standard reference dataset construction
  • Automated annotation pipeline for scale

UMAP Representation

Real vs Generated Cell Distributions

PDAC (Test Information)

PDAC Real Data UMAP Plot

Real Data

PDAC Generated Data UMAP Plot

Generated Data

PDAC Real vs Generated Data Comparison UMAP Plot

Real vs Generated

Virtual Cell Model maintains high performance in complex cancer datasets, scoring MMD ≈ 0.7 / WD ≈ 10.6

3.4M+
Cancer Cells
From over 468 patients across multiple cancer types
PDAC, HGSOC, SCLC, Breast Cancer, NETs
8.5M+
Normal Cells
From over 933 healthy donors
Ever-expanding through web crawling & automatic annotation